Skip to content

Dr. Delphine Braecke

Active
Private limited companyfounded 2019active for 6 yearsHoogstraat 21, 8780 Oostrozebeke, BelgiumKBO/BCE: BE 0737.635.609

From the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Delphine Braecke has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €189,963 and a net result of €267,963. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 25% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 13-11-2019 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.298.443.308 8780 Oostrozebeke, since 13-11-2019
Financial year end
30 June
Peppol
Reachable since 30-01-2025

Board and ownership

Board
  • Braecke DelphineDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€445,538
▲ 23.5%
Turnover
≈ €690,000
estimated
Profit
€267,963
▲ 35.0%
Equity
€189,963
▼ 5.0%
Total assets
€640,265
▼ 44.3%
Staff
1 FTE
=
Filed on 24-10-2025, 99 days before the deadlinePDF
Score breakdownraises riskFounded in 2019lowers riskSector: Human health activities (NACE 86)Size: total assets €640,265Figures for financial year 2025 (filed on 27-10-2025)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 41% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 55+13
equity 29.7% of total assets
Liquidity 54+12
short-term debt 32.6% · cash 14.3%
Profitability 100+10
return on assets 41.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.47 (1.17 in 2024), below the usual 1.5. Short-term debt is 32.6% and cash 14.3% of total assets. 70.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 26% of them on solvency, 28% on liquidity, 80% on profitability and 30% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €640,265
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 27-10-2025)
NBB · annual accounts
raises risk · Founded in 2019
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 24-10-2025, 99 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
99 days early
2024
53 days early
2023
41 days early
2022
7 days early
2021
28 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 46 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 21 December (4 of the last 5 accounts filed within 34 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end01-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 93% of companies in human healthsector median €60,139 · 20,665 companies €267,963 View
  • Positive: Result rose in 2025from €198,480 to €267,963 ▲ 35.0% View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View
  • Positive: 5 profitable years in a rowprofit 2025: €267,963 5 years View

Comparable companies

These companies have the same main activity as Dr. Delphine Braecke: general medical practice (NACE 86210). They are comparable in size and age: total assets between €583,000 and €723,000, founded between 2019 and 2020.

CompanyTotal assetsGross margin
Dr. Delphine Braecke Oostrozebeke€640,265€445,538
DOKTERS PRIEM-VERLEYE Brugge€595,510€410,365
Huisartsenpraktijk Bruno BOONE Brugge€616,025€411,889
LE VINH NGUYEN NGOC Anderlecht€653,935€419,351
Huisartsenwachtpost Noord-Limburg-VZW Pelt€722,593€469,163
DOKTER JANNEKE BERNAERT Brugge€582,665€367,783
Dr. Ewout Leys Algemene Geneeskunde Blankenberge€682,229€357,830
Full comparison

Documents

Annual accounts at the NBB

All 5 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Delphine Braecke

What is the company number of Dr. Delphine Braecke?
The company number of Dr. Delphine Braecke is 0737.635.609. The VAT number is the same number with BE in front: BE 0737.635.609.
Where is Dr. Delphine Braecke based?
The registered office is at Hoogstraat 21, 8780 Oostrozebeke.Company details
What does Dr. Delphine Braecke do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Delphine Braecke?
The legal form of Dr. Delphine Braecke is Private limited company (BV).
When was Dr. Delphine Braecke founded?
Dr. Delphine Braecke was founded on 13-11-2019.
Is Dr. Delphine Braecke still active?
Yes, Dr. Delphine Braecke is an active enterprise in the KBO register.
How many employees does Dr. Delphine Braecke have?
Dr. Delphine Braecke had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Dr. Delphine Braecke?
The turnover in financial year 2025 is ≈ €690,000. This figure is estimated from the gross margin of €445,538 and 36 comparable companies (NACE 862). It probably lies between €620,000 and €860,000.
Is Dr. Delphine Braecke profitable?
In financial year 2025, Dr. Delphine Braecke made a profit of €267,963.
Where can I find the annual accounts of Dr. Delphine Braecke?
Dr. Delphine Braecke filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Dr. Delphine Braecke due?
Dr. Delphine Braecke must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.